Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells
- 1 June 2000
- journal article
- case report
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 25 (12), 1285-1287
- https://doi.org/10.1038/sj.bmt.1702443
Abstract
Reports of neurological toxicity of cryopreserved stem cell infusion are infrequent. Three of 179 consecutive patients experienced significant neurological events in this context. Transient global amnesia developed following infusion in one patient and in the other two, cerebral infarction occurred. Profound hypotension, bradyarrhythmias or hypoxia were not associated with any of these episodes. These events may have been related to infused DMSO, which in the non-transplant setting has been associated with neurological toxicity and local infusion of which has resulted in acute vasospasm in animal models. These cases suggest that infusion of cryopreserved stem cells may result in cerebrovascular ischaemia. Bone Marrow Transplantation (2000) 25, 1285-1287.Keywords
This publication has 6 references indexed in Scilit:
- Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 casesBone Marrow Transplantation, 1999
- Diffusion-weighted MRI characterizes the ischemic lesion in transient global amnesiaNeurology, 1998
- THE AETIOLOGY OF TRANSIENT GLOBAL AMNESIABrain, 1990
- Clinical toxicity of cryopreserved bone marrow graft infusionBlood, 1990
- DIMETHYLSULPHOXIDE-INDUCED ENCEPHALOPATHYThe Lancet, 1989
- DIMETHYLSULPHOXIDE-INDUCED TOXICITYThe Lancet, 1980